
Tilray Brands Investor Relations Material
Latest events

Q4 2025
Tilray Brands
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tilray Brands Inc
Access all reports
Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It offers sativa, indica, and hybrid medical marijuana grown and sold under the Tilray brand; cannabis oils; capsules; and accessories for administration of medical cannabis including oral syringes and syringe applicators. The company also provides Tetrahydrocannabinol, Cannabidiol, Sativa, Indica, Hybrid, CBD Energy Shot; Live Resin Vape Pen Cartridges; and Cannabis oil. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
TLRY
Country
🇨🇦 Canada